At least 357,762 cases and 12,431 deaths.
See the Ministry of Health COVID-19 page (in Indonesian) for updates and the full list of locations reporting local transmission. The National COVID-19 hotline is 119 ext 9.
Status: Outbreak, cases increasing.
18 October: More than 70,000 cases have been confirmed since the start of the month. Totals of 357,000 cases and 12,431 deaths are reported to date, with Jakarta accounting for over 90,000 cases and 2,000 deaths. The large scale social restrictions in Jakarta were eased into a transitional phase on 12 October.
14 October: On average over 4,200 cases have been reported each day in the last week. The total number of confirmed cases is now 344,749, of which 12,156 people have died.
The President has stated (in Indonesian) that 12 districts and cities are responsible for 30% of new cases nationally, each with over 1,000 active cases; the five districts of Jakarta, Ambon City, Bekasi City, Bogor Regency, Depok City, Jayapura City, Padang City and Pekanbaru City. The Government has announced (in Indonesian) that isolation bed capacity in the 11 priority provinces is around 40-60%. The number of isolation beds in the hotspot area of Jakarta has been increased to 6,000 in the last month.
Media is reporting that front line staff including health workers, paramedics, public officials, military and police officers, teaching staff will begin to receive the experimental CanSino COVID-19 vaccine from next month.
9 October: A new daily record of 4,850 cases has been reported. In total there are 320,564 cases confirmed and 11,580 deaths. With over 1,000 new cases per day in Jakarta for the last month, almost two-thirds of the 3,116 beds at the isolation centres of Wisma Atlet are occupied. Additional beds for asymptomatic cases are being prepared at various guesthouses and hotels in Jakarta.
6 October: New daily cases have been above 4,000 on average during the last week. Jakarta continues to be a hotspot reporting over 1,000 cases each day. There have been 307,210 cases confirmed, of which 11, 253 people have died. Hypertension, diabetes and health issues are the leading comorbidites in fatal case.
The national food and drug regulator (BPOM) has approved (in Indonesian) the antiviral remdesivir for treatment of hospitalised COVID-19 patients. Avigan has already been approved for use in COVID-19 treatment.
1 October: Cases have sharply increased during September, with an additional 109,437 cases confirmed during the month. The nation has reported 287,008 cases and 10,740 deaths. Males continue to be slightly more affected than females. All 34 provinces are reporting ongoing local transmission.
See the September news updates here.